![](/images/graphics-bg.png)
Biological Evaluation of Newly Synthesized Biaryl Guanidine Derivatives to Arrest β-Secretase Enzymatic Activity Involved in Alzheimer’s Disease
Joint Authors
Rizvanov, Albert A.
Ali, Sayyad
Khan, Fahad
Iqbal, Jamshed
Babak, Borhan
Hussain, Izhar
Murtaza, Ghulam
Mehmood, Rubada
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-05-11
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Proteases BACE1 (β-secretases) enzymes have been recognized as a promising target associated with Alzheimer’s disease (AD).
This study was carried out on the principles of molecular docking, chemical synthesis, and enzymatic inhibition of BACE1 enzymes via biaryl guanidine-based ligands.
Based on virtual screening, thirteen different compounds were synthesized and subsequently evaluated via in vitro and in vivo studies.
Among them, 1,3-bis(5,6-difluoropyridin-3-yl)guanidine (compound (9)) was found the most potent (IC50=97±0.91 nM) and active to arrest (99%) β-secretase enzymes (FRET assay).
Furthermore, it was found to improve the novel object recognition test and Morris water maze test significantly (p<0.05).
Improved pharmacokinetic parameters, viz., Log Po/w (1.76), Log S (-2.73), and better penetration to the brain (BBB permeation) with zero Lipinski violation, made it possible to hit the BACE1 as a potential therapeutic source for AD.
American Psychological Association (APA)
Ali, Sayyad& Mehmood, Rubada& Khan, Fahad& Murtaza, Ghulam& Rizvanov, Albert A.& Iqbal, Jamshed…[et al.]. 2020. Biological Evaluation of Newly Synthesized Biaryl Guanidine Derivatives to Arrest β-Secretase Enzymatic Activity Involved in Alzheimer’s Disease. BioMed Research International،Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1137874
Modern Language Association (MLA)
Ali, Sayyad…[et al.]. Biological Evaluation of Newly Synthesized Biaryl Guanidine Derivatives to Arrest β-Secretase Enzymatic Activity Involved in Alzheimer’s Disease. BioMed Research International No. 2020 (2020), pp.1-11.
https://search.emarefa.net/detail/BIM-1137874
American Medical Association (AMA)
Ali, Sayyad& Mehmood, Rubada& Khan, Fahad& Murtaza, Ghulam& Rizvanov, Albert A.& Iqbal, Jamshed…[et al.]. Biological Evaluation of Newly Synthesized Biaryl Guanidine Derivatives to Arrest β-Secretase Enzymatic Activity Involved in Alzheimer’s Disease. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1137874
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1137874